Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Board

Showing results (241-250 of 338) with videos related to

Pageof 34
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 1999
Pesticides and Parkinson's diseaseD G Le Couteur, A J McLean, M C Taylor, et al.
Cancers|December 24, 2021
The Antiviral Drug Efavirenz in Breast Cancer Stem Cell TherapyPey-Tsyr Chiou, Stephen Ohms, Philip G Board, et al.
Neurology|May 26, 2004
Glutathione transferase Omega class polymorphisms in Parkinson diseaseA K Whitbread, G D Mellick, P A Silburn, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2020
Efavirenz as a potential drug for the treatment of triple-negative breast cancersP-T Chiou, S Ohms, P G Board, et al.
Princess Takamatsu Symposia|January 1, 1990
Molecular genetics of the human glutathione S-transferaseP G Board, P N Johnston, V L Ross, et al.
Journal of Biomolecular NMR|July 26, 2005
1H, 13C and 15N assignments for the II-III loop region of the skeletal dyhydropyridine receptorYanfang Cui, Yamuna Karunasekara, Peta J Harvey, et al.
Cell Calcium|October 7, 2006
The Mu class glutathione transferase is abundant in striated muscle and is an isoform-specific regulator of ryanodine receptor calcium channelsYasser Abdellatif, Dan Liu, Esther M Gallant, et al.
British Journal of Cancer|March 1, 1992
Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myelomaM E Linsenmeyer, S Jefferson, M Wolf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2001
Zeta class glutathione transferase polymorphisms and Parkinson's diseaseM C Taylor, P G Board, A C Blackburn, et al.
Plos One|October 15, 2011
3D Mapping of the SPRY2 domain of ryanodine receptor 1 by single-particle cryo-EMAlex Perálvarez-Marín, Hanshen Tae, Philip G Board, et al.
Pageof 34

Showing results (241-250 of 338) with videos related to

Sort By:
Pageof 34
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 1999
Pesticides and Parkinson's diseaseD G Le Couteur, A J McLean, M C Taylor, et al.
Cancers|December 24, 2021
The Antiviral Drug Efavirenz in Breast Cancer Stem Cell TherapyPey-Tsyr Chiou, Stephen Ohms, Philip G Board, et al.
Neurology|May 26, 2004
Glutathione transferase Omega class polymorphisms in Parkinson diseaseA K Whitbread, G D Mellick, P A Silburn, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2020
Efavirenz as a potential drug for the treatment of triple-negative breast cancersP-T Chiou, S Ohms, P G Board, et al.
Princess Takamatsu Symposia|January 1, 1990
Molecular genetics of the human glutathione S-transferaseP G Board, P N Johnston, V L Ross, et al.
Journal of Biomolecular NMR|July 26, 2005
1H, 13C and 15N assignments for the II-III loop region of the skeletal dyhydropyridine receptorYanfang Cui, Yamuna Karunasekara, Peta J Harvey, et al.
Cell Calcium|October 7, 2006
The Mu class glutathione transferase is abundant in striated muscle and is an isoform-specific regulator of ryanodine receptor calcium channelsYasser Abdellatif, Dan Liu, Esther M Gallant, et al.
British Journal of Cancer|March 1, 1992
Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myelomaM E Linsenmeyer, S Jefferson, M Wolf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2001
Zeta class glutathione transferase polymorphisms and Parkinson's diseaseM C Taylor, P G Board, A C Blackburn, et al.
Plos One|October 15, 2011
3D Mapping of the SPRY2 domain of ryanodine receptor 1 by single-particle cryo-EMAlex Perálvarez-Marín, Hanshen Tae, Philip G Board, et al.
Pageof 34